These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16205081)

  • 1. Skin site mast cell numbers correlate with rates of nodular growth, but not incidence, of basal cell carcinoma.
    Weber A; Maurer M
    Dermatology; 2005; 211(3):298-9. PubMed ID: 16205081
    [No Abstract]   [Full Text] [Related]  

  • 2. [Skin photoaging and basal cell carcinoma: the role of mast cells].
    Smirnova IO
    Klin Med (Mosk); 2005; 83(7):55-8. PubMed ID: 16117428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Reduction in Inflammatory Macrophages May Contribute to Skin Cancer Chemoprevention by Nicotinamide.
    Minocha R; Martin AJ; Chen AC; Scolyer RA; Lyons JG; McKenzie CA; Madore J; Halliday GM; Damian DL
    J Invest Dermatol; 2019 Feb; 139(2):467-469. PubMed ID: 30244097
    [No Abstract]   [Full Text] [Related]  

  • 4. Percutaneous application of peptidoglycan from Staphylococcus aureus induces an increase in mast cell numbers in the dermis of mice.
    Matsui K; Nishikawa A
    Clin Exp Allergy; 2005 Mar; 35(3):382-7. PubMed ID: 15784119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xeroderma pigmentosum skin: an immune privilege site for tumor development.
    Abid K; El Mezni F; Kamoun MR; Fazaa B; Zermani R; Hadouchi C; Hamzaoui K
    J Cutan Pathol; 2010 Apr; 37(4):452-9. PubMed ID: 19719835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in CD30 ligand/CD153 and TNF-alpha expressing mast cells in basal cell carcinoma.
    Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Nilsson G; Harvima IT
    Cancer Immunol Immunother; 2007 Sep; 56(9):1407-15. PubMed ID: 17268792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An immunohistochemical study on basal cell epithelioma using anti-keratin monoclonal antibodies].
    Shimizu N
    Nihon Hifuka Gakkai Zasshi; 1987 May; 97(6):691-7. PubMed ID: 2442439
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
    Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
    Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin tumors and reactive cellular infiltrate: further studies.
    Claudatus JC; d'Ovidio R; Lospalluti M; Meneghini CL
    Acta Derm Venereol; 1986; 66(1):29-34. PubMed ID: 2424211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of skin cancer is growing rapidly.
    Nouri K
    Int J Dermatol; 2004 Aug; 43(8):622. PubMed ID: 15304193
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bound IgG, IgM, IgA and complement in the epidermis of the growth zone of skin tumors].
    Beletskaia LV; Berenbeĭn BA; Silagadze DG; Ezhov NIa
    Vestn Dermatol Venerol; 1981 Jan; (1):13-6. PubMed ID: 7210863
    [No Abstract]   [Full Text] [Related]  

  • 13. Mast cells have prognostic value in Merkel cell carcinoma.
    Beer TW; Ng LB; Murray K
    Am J Dermatopathol; 2008 Feb; 30(1):27-30. PubMed ID: 18212540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of stem cell factor in basal cell carcinoma.
    Yamamoto T; Katayama I; Nishioka K
    Br J Dermatol; 1997 Nov; 137(5):709-13. PubMed ID: 9415229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal cell carcinoma of the skin: a biologic marker for visceral malignancy.
    Debrowsky R; Hukill PB; Lundy JL
    Conn Med; 1978 Jan; 42(1):8-10. PubMed ID: 620537
    [No Abstract]   [Full Text] [Related]  

  • 16. Trends in the incidence of basal cell carcinoma by histopathological subtype.
    Arits AH; Schlangen MH; Nelemans PJ; Kelleners-Smeets NW
    J Eur Acad Dermatol Venereol; 2011 May; 25(5):565-9. PubMed ID: 20840348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An audit of the completeness of non-melanoma skin cancer registration in Greater Glasgow.
    Lucke TW; Hole DJ; Mackie RM
    Br J Dermatol; 1997 Nov; 137(5):761-3. PubMed ID: 9415237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial variation in incidence of nonmelanoma skin cancers.
    Verne J
    Br J Dermatol; 2011 Apr; 164(4):694-5. PubMed ID: 21457198
    [No Abstract]   [Full Text] [Related]  

  • 19. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996.
    Harris RB; Griffith K; Moon TE
    J Am Acad Dermatol; 2001 Oct; 45(4):528-36. PubMed ID: 11568742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictions of skin cancer incidence in the Netherlands up to 2015.
    de Vries E; van de Poll-Franse LV; Louwman WJ; de Gruijl FR; Coebergh JW
    Br J Dermatol; 2005 Mar; 152(3):481-8. PubMed ID: 15787817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.